Capital Product Stock Target Price and Analyst Consensus

CPLP
 Stock
  

USD 14.12  0.04  0.28%   

The current analyst and expert consensus on Capital Product is Strong Buy, with 3 strong buy opinions. The current projected Capital Product target price consensus is 18.67 with 3 analyst opinions. The most common way Capital Product Part analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Capital Product executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Capital Product. We encourage you to use your own analysis of Capital Product Part to validate this buy or sell advice. Capital Product buy-or-sell recommendation module provides average expert sentiment on the projected Capital Product Part target price to derive its highest and lowest estimates based on projected price volatility of 1.527. Continue to Macroaxis Advice on Capital Product to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Capital Product Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Capital target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Capital target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions3
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Capital analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Capital stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Capital Product Part, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Capital Product Target Price Projection

Capital Product's current and average target prices are 14.12 and 18.67, respectively. The current price of Capital Product is the price at which Capital Product Part is currently trading. On the other hand, Capital Product's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Capital Product Market Quote on 30th of November 2022

Low Price13.79Odds
High Price14.24Odds

14.12

Target Price

Analyst Consensus On Capital Product Target Price

Low Estimate17.0Odds
High Estimate20.0Odds
Number of Analysts3
Standard Deviation1.527

18.666

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Capital Product Part and the information provided on this page.

Capital Product Analyst Ratings

Capital Product's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Capital Product stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Capital Product's financials, market performance, and future outlook by experienced professionals. Capital Product's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Capital Product Target Price Projections

Capital Product's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Capital Product Part and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Capital depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Capital Product Part including analysis of its current option contracts.
Capital Product's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 23.68 with a put-to-call open interest ratio of 0.08 over 22 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 42, with calls trading at the volume of 75. This yields a 0.56 put-to-call volume ratio. The Capital Product option chain provides detailed quote and price information for the current Capital Product Part option contracts. It shows all of Capital Product's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

Capital Product option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Capital Product's lending market. For example, when Capital Product's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Capital Product, he or she must hedge the risk by shorting Capital Product stock over its option's life.
The chart above shows Capital Product's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Capital Product's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Capital Product's option, there is no secondary market available for investors to trade.

Capital Product Maximum Pain Price across 2022-12-16 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Capital Product close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Capital Product's stock options are financial instruments that give investors the right to buy or sell shares of Capital Product Part common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Capital stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Capital Product's stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Capital Product to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Capital Current Options Market Mood

Capital Product's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Capital Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Capital Product's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Capital Product's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Capital Product's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Capital Product Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Capital Product is a key component of Capital Product valuation and have some predictive power on the future returns of a Capital Product.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Capital Product's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Capital Product in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
12.0414.0416.04
Details
Intrinsic
Valuation
LowReal ValueHigh
12.6716.4318.43
Details
Naive
Forecast
LowNext ValueHigh
12.3114.3116.30
Details
Earnings
Estimates (3)
LowProjected EPSHigh
2.142.392.52
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Capital Product. Your research has to be compared to or analyzed against Capital Product's peers to derive any actionable benefits. When done correctly, Capital Product's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Capital Product Part.

Additional Capital Product Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Capital Product is a key component of Capital Product valuation and have some predictive power on the future returns of a Capital Product.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Capital Product's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Capital Product in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
12.0414.0416.04
Details
Intrinsic
Valuation
LowReal ValueHigh
12.6716.4318.43
Details
Naive
Forecast
LowNext ValueHigh
12.3114.3116.30
Details
Earnings
Estimates (3)
LowProjected EPSHigh
2.142.392.52
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Capital Product. Your research has to be compared to or analyzed against Capital Product's peers to derive any actionable benefits. When done correctly, Capital Product's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Capital Product Part.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Diversified Assets
Invested over 90 shares
Macroaxis Index
Invested over 90 shares
Baby Boomer Prospects
Invested over 90 shares
Continue to Macroaxis Advice on Capital Product to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running Capital Product Part price analysis, check to measure Capital Product's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capital Product is operating at the current time. Most of Capital Product's value examination focuses on studying past and present price action to predict the probability of Capital Product's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Capital Product's price. Additionally, you may evaluate how the addition of Capital Product to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
The data published in Capital Product's official financial statements usually reflect Capital Product's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Capital Product Part. For example, before you start analyzing numbers published by Capital accountants, it's critical to develop an understanding of what Capital Product's liquidity, profitability, and earnings quality are in the context of the Industrials space in which it operates.
Please note, the presentation of Capital Product's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Capital Product's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Capital Product's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Capital Product Part. Please utilize our Beneish M Score to check the likelihood of Capital Product's management to manipulate its earnings.